Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Total 13F shares
-
70,038,330
-
Share change
-
+998,726
-
Total reported value
-
$15,270,649,646
-
Put/Call ratio
-
40%
-
Price per share
-
$218.80
-
Number of holders
-
724
-
Value change
-
+$210,523,947
-
Number of buys
-
364
-
Number of sells
-
341
Institutional Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2025
As of 30 Jun 2025,
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) was held by
724 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,038,330 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, Bank of New York Mellon Corp, BROWN ADVISORY INC, Artisan Partners Limited Partnership, GEODE CAPITAL MANAGEMENT, LLC, APG Asset Management N.V., VAN ECK ASSOCIATES CORP, and MORGAN STANLEY.
This page lists
725
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.